Myfortic better for kidney patients -Novartis
Posted on: Wednesday, 19 October 2005, 00:59 CDT
ZURICH (Reuters) - Novartis said on Wednesday its Myfortic transplant rejection treatment improved quality of life for kidney transplant patients switching to the drug from conventional treatments.
Novartis said a study showed that 66 percent of patients who suffered gastrointestinal complaints while on a conventional drug after surgery reported an improvement in their symptoms when they switched to Myfortic.
Source: REUTERS
Related Articles
Rating: 3.0 / 5 (4 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds